Share price
+0.11%
Calendar
| Est. time* | ||
| 2025-08-12 | 07:50 | Quarterly Report 2025-Q2 |
| 2025-03-07 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2025-03-06 | - | Annual General meeting |
| 2025-02-05 | - | Year-end Report 2024 |
| 2024-08-14 | - | Quarterly Report 2024-Q2 |
| 2024-03-07 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2024-03-06 | - | Annual General meeting |
| 2024-02-06 | - | Year-end Report 2023 |
| 2023-08-15 | - | Quarterly Report 2023-Q2 |
| 2023-03-09 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2023-03-08 | - | Annual General meeting |
| 2023-02-07 | - | Year-end Report 2022 |
| 2022-08-16 | - | Quarterly Report 2022-Q2 |
| 2022-03-11 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2022-03-10 | - | Annual General meeting |
| 2022-02-08 | - | Year-end Report 2021 |
| 2021-08-12 | - | Quarterly Report 2021-Q2 |
| 2021-03-08 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2021-03-05 | - | Annual General meeting |
| 2021-02-09 | - | Year-end Report 2020 |
| 2020-08-17 | - | Quarterly Report 2020-Q2 |
| 2020-03-11 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2020-03-10 | - | Annual General meeting |
| 2020-02-04 | - | Year-end Report 2019 |
| 2019-08-14 | - | Quarterly Report 2019-Q2 |
| 2019-03-20 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2019-03-19 | - | Annual General meeting |
| 2019-02-19 | - | Year-end Report 2018 |
| 2018-08-15 | - | Quarterly Report 2018-Q2 |
| 2018-03-23 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2018-03-22 | - | Annual General meeting |
| 2018-02-22 | - | Year-end Report 2017 |
| 2017-08-14 | - | Quarterly Report 2017-Q2 |
| 2017-05-09 | - | Quarterly Report 2017-Q1 |
| 2017-03-28 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2017-03-27 | - | Annual General meeting |
| 2017-02-23 | - | Year-end Report 2016 |
| 2016-11-10 | - | Quarterly Report 2016-Q3 |
| 2016-08-17 | - | Quarterly Report 2016-Q2 |
| 2016-05-25 | - | Split DEMANT 1:5 |
| 2016-05-10 | - | Quarterly Report 2016-Q1 |
| 2016-04-08 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2016-04-07 | - | Annual General meeting |
| 2016-03-01 | - | Year-end Report 2015 |
| 2015-11-12 | - | Quarterly Report 2015-Q3 |
| 2015-08-14 | - | Quarterly Report 2015-Q2 |
| 2015-05-07 | - | Quarterly Report 2015-Q1 |
| 2015-04-10 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2015-04-09 | - | Annual General meeting |
| 2015-02-26 | - | Year-end Report 2014 |
| 2014-11-13 | - | Quarterly Report 2014-Q3 |
| 2014-08-14 | - | Quarterly Report 2014-Q2 |
| 2014-05-08 | - | Quarterly Report 2014-Q1 |
| 2014-04-10 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2014-04-09 | - | Annual General meeting |
| 2014-02-27 | - | Year-end Report 2013 |
| 2013-11-05 | - | Quarterly Report 2013-Q3 |
| 2013-08-14 | - | Quarterly Report 2013-Q2 |
| 2013-05-07 | - | Quarterly Report 2013-Q1 |
| 2013-04-10 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2013-04-09 | - | Annual General meeting |
| 2013-02-26 | - | Year-end Report 2012 |
| 2012-11-07 | - | Quarterly Report 2012-Q3 |
| 2012-08-16 | - | Quarterly Report 2012-Q2 |
| 2012-05-10 | - | Quarterly Report 2012-Q1 |
| 2012-04-12 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2012-04-11 | - | Annual General meeting |
| 2012-02-29 | - | Year-end Report 2011 |
| 2011-11-10 | - | Quarterly Report 2011-Q3 |
| 2011-08-19 | - | Quarterly Report 2011-Q2 |
| 2011-05-12 | - | Quarterly Report 2011-Q1 |
| 2011-04-14 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
| 2011-04-13 | - | Annual General meeting |
| 2010-11-16 | - | Quarterly Report 2010-Q3 |
| 2010-04-08 | - | Ex-date Ordinary Dividend DEMANT 0.00 DKK |
Description
| Country | Denmark |
|---|---|
| List | Large Cap Copenhagen |
| Sector | Health care |
| Industry | Medical technology |
12.8.2022 18:32:54 CEST | Demant A/S | Investor Nyheder
Investor news | 12. august 2022 |
Sammenligningstal for 2021
Den 27. april 2022 meldte Demant ud, at man havde besluttet at afvikle sin Hearing Implants-forretning. I henhold til IFRS 5 – Anlægsaktiver bestemt for salg og ophørte aktiviteter og som tidligere meldt ud indregnes Hearing Implants derfor i koncernens finansielle rapportering og regnskab som en ophørende aktivitet, og sammenligningstallene for 2021 er justeret for at afspejle dette. Med henblik på afstemning af disse justerede tal med de rapporterede tal har vi vedhæftet justerede resultatopgørelser (ureviderede) for følgende rapporteringsperioder: H1 2021, H2 2021 og FY 2021.
Bemærk venligst, at det vedhæftede dokument kun indeholder historiske tal for at lette sammenligningen mellem historiske og fremtidige resultater.
Yderligere information: Søren Nielsen, koncernchef og adm. direktør Telefon +45 3917 7300 | Øvrige kontaktpersoner: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Trine Kromann-Mikkelsen, VP Corporate Communication and Relations |
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.